Evaluation of clinical need, effectiveness, and safety of the first myosin inhibitor mavacamten in real world patients

Authors: K Seuthe, A Feidakis, R Nies, M Bruewer, L Pennig, U Mons, S Baldus, R Pfister

Published: 2024-10-28

DOI: 10.1093/eurheartj/ehae666.2020

Source: Full article